Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 3.1
0.324 %
$ 283 M
Market Cap
-6.89
P/E
Price Target
Average
209.68%
Revenue Forecast
Estimate
54.72%
EBIT
Estimate
--110.55%
Net Income
Estimate
46.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aquestive Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AQST of $9.6 , with forecasts ranging from
a
low of
$7 to a high of $12 .
AQST Lowest Price Target
Wall Street Target
7 USD
125.81%
AQST Average Price Target
Wall Street Target
9.6 USD
209.68%
AQST Highest Price Target
Wall Street Target
12 USD
287.10%
REVENUE FORECAST
Revenue Forecast Chart AQST
EBIT FORECAST
EBIT Forecast Chart AQST
NET INCOME FORECAST
Net Income Chart AQST